Ask Warren

Samsung Biologics

207940 · KOSPI · ₩SBL · 삼성바이오로직스

₩1,374,000▼ ₩78,000 (5.37%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 23, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서

    Predicted impact: Low

    Oct 22, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)

    Predicted impact: Low

    Oct 22, 2026Open on DART
  • [Amended] Earnings Outlook Based on Consolidated Financial Statements (Fair Disclosure)[기재정정]연결재무제표기준영업실적등에대한전망(공정공시)

    Predicted impact: Low

    Oct 21, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)

    Predicted impact: Medium

    Preliminary consolidated results disclosed; no comparable figures given, so surprise size cannot be judged.

    Oct 21, 2026Open on DART
  • Amended: Acquisition of shares in another company[기재정정]타법인주식및출자증권취득결정(종속회사의주요경영사항)

    Predicted impact: Low· Actual: +3.2% vs sector, volume 2.6× normal (5 trading days)

    Oct 16, 2026Open on DART
  • [Amended] Material Matters Report (Decision on Acquisition of Equity Securities of Other Corporations)[기재정정]주요사항보고서(타법인주식및출자증권양수결정)

    Predicted impact: Low· Actual: +3.2% vs sector, volume 2.6× normal (5 trading days)

    Oct 16, 2026Open on DART
  • Advance Notice of Earnings Results Disclosure (Informational Disclosure)결산실적공시예고(안내공시)Oct 7, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Oct 6, 2026Open on DART
  • Major sales or supply contract단일판매ㆍ공급계약체결(자율공시)Oct 2, 2026Open on DART
  • Rights Offering New Share Issue Price (Informational Disclosure)유상증자신주발행가액(안내공시)Oct 1, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서Oct 1, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Oct 1, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Oct 1, 2026Open on DART
  • Prospectus투자설명서Sep 14, 2026Open on DART
  • Securities registration statement효력발생안내( 2026.8.28. 제출 증권신고서(지분증권) )Sep 14, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Sep 11, 2026Open on DART
  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 10, 2026Open on DART
  • Major sales or supply contract단일판매ㆍ공급계약체결Sep 10, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Sep 7, 2026Open on DART
  • Amended: Investor relations (IR) event[기재정정]기업설명회(IR)개최(안내공시)Sep 3, 2026Open on DART
  • Acquisition of shares in another company타법인주식및출자증권취득결정(종속회사의주요경영사항)Aug 31, 2026Open on DART
  • Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]대규모기업집단현황공시[분기별공시(개별회사용)]Aug 31, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Aug 28, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최(안내공시)Aug 28, 2026Open on DART
  • Securities registration statement증권신고서(지분증권)Aug 28, 2026Open on DART
  • [Amended] Material Matters Report (Decision on Acquisition of Equity Securities of Other Corporations)[기재정정]주요사항보고서(타법인주식및출자증권양수결정)Aug 28, 2026Open on DART
  • Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Aug 28, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Matters Concerning Payment Amounts by Payment Method and Payment Period, and Dispute Mediation Bodies지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항Aug 14, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 6, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Aug 3, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Jul 31, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Jul 23, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Samsung Biologics / 삼성바이오로직스 / 207940 / KRX:207940

Source: KRX statistical information